Neural Noise
Search
Search
Dark mode
Light mode
Browse
Tag: biomarker
12 items with this tag.
Modified:
Feb 26, 2026
TMS–EEG: prefrontal intracortical inhibition and cognitive dysfunction in post-COVID-19
biomarker
cerebellar
clinical-neurotechnology
eeg
policy-regulation
tacs
tms
Modified:
Feb 21, 2026
TMS-induced E-field measurement in head phantoms
biomarker
eeg
motor-imagery
tms
Modified:
Feb 26, 2026
Theta-cordance as biomarker of iTBS treatment response in treatment-resistant depression
biomarker
cerebellar
clinical-neurotechnology
ecog
eeg
policy-regulation
tacs
tms
Modified:
Feb 26, 2026
Sleep scoring in neurodegenerative diseases: towards new rules
biomarker
cerebellar
clinical-neurotechnology
eeg
other-clinical
policy-regulation
tacs
tms
Modified:
Feb 26, 2026
Mega-analysis of EEG frontal-midline theta neurofeedback: learning dynamics and response profiles
biomarker
eeg
eeg-based-bci
neurofeedback
policy-regulation
tacs
tms
Modified:
Feb 26, 2026
Low-intensity transcranial electric stimulation: ESBS/IFCN safety, ethics and regulation guidelines
biomarker
clinical-neurotechnology
eeg
policy-regulation
tacs
tdcs
tms
trns
Modified:
Feb 24, 2026
fNIRS biomarkers for stratifying poststroke cognitive impairment
biomarker
clinical-neurotechnology
cognitive-impairment
computational-neuroscience
fnirs
hd-semg
myoelectric
stroke
Modified:
Feb 26, 2026
Effects of cerebellar tACS on balance and gait in healthy subjects
biomarker
cerebellar
clinical-neurotechnology
eeg
policy-regulation
tacs
tms
Modified:
Feb 26, 2026
EEG biomarker in Fragile X syndrome (translational)
biomarker
clinical-neurotechnology
eeg
gamma
motor-imagery
tacs
tms
Modified:
Feb 26, 2026
Cost of scientific regulatory misclassification of non-invasive brain stimulation in Europe
biomarker
cerebellar
eeg
europe
policy-regulation
tacs
tms
Modified:
Feb 26, 2026
Connectomic tACS with phase-dependent network effects in aphasia
biomarker
cerebellar-tms
clinical-neurotechnology
connectomics
tacs
Modified:
Feb 26, 2026
Combined TMS and tACS neuroplasticity in tremor-dominant Parkinson's disease
biomarker
cerebellar
clinical-neurotechnology
eeg
parkinsons
policy-regulation
tacs
tms